Antoine N Saliba

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Antoine N Saliba

Dec 23, 2024, 13:42 | Blog

Pre-treatment and response-based prognostic tools for newly diagnosed AML - American Journal of Hematology

American Journal of Hematology shared a post on X: “The Mayo genetic risk models offer…

Dec 23, 2024, 11:55 | Drugs

Talha Badar: Venetoclax and Azacitidine for elderly AML ineligible for intensive Induction

Talha Badar shared on X: “Brief overview of venetoclax+azacitidine for elderly AML ineligible for intensive…

Dec 19, 2024, 12:39 | Science

Mayo Clinic Genetic Risk models in Venetoclax-HMA treated AML

An article was published on Wiley Online Library by Naseema Gangat et al., titled "Mayo…

Nov 7, 2024, 15:22 | Blog

Talha Badar: Prognostic impact of ‘multi-hit’ versus ‘single-hit’ TP53 alteration in patients with AML

Talha Badar posted on X about recent paper by him as first author, titled "Prognostic…

Jul 8, 2024, 16:34 | Insight

Aref Al-Kali: AML is hanging with use of FLT3i and Allo BMT

Aref Al-Kali, Hematologist/Oncologist at Mayo Clinic, shared on X: "Outcome of t6;9 AML changing with…

All: 5 Posts: 1 - 100

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

'

Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram

'

WHO Takes a Creative Leap in Raising Awareness for Colorectal Cancer

'

Highlights from 2025 EAU Annual Meeting on Urology

'

OncoDaily and Big Whig Media Announce Partnership: Global Oncology Media Leader Joins Forces with Premier Washington, D.C. Multimedia Powerhouse

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023